WHO WE ARE

Harel is a seasoned executive and entrepreneur in the healthcare space, with an extensive and proven track record. Harel brings over 19 years of experience in leadership positions in the corporate world as well as the start-up sector, including the United States, Europe, and Israel. Harel founded MEDX Ventures Group in 2010, a unique investment and management firm, and serves as its Company Group Chairman.

Harel founded XACT Robotics in 2013 and serves as its Executive Chairman and President. He also serves as the CEO, President & Chairman of Microbot Medical Inc. (Nasdaq: MBOT), where he co-founded the company in 2011 and led it through its successful listing on NASDAQ in 2016. In addition, Harel is the founder and Chairman of MEDX Xelerator LP, a government supported medical devices incubator in Israel, with a partnership between MEDX Ventures Group, Boston Scientific Corporation, Intellectual Ventures, and Sheba Medical Center. Until 2013, Harel served on the board of directors at ConTIPI Ltd., and played an instrumental role in its commercial efforts, resulting in its acquisition by Kimberly Clark Corporation.

Until 2010, Harel served as a Worldwide Group Marketing Director at Johnson & Johnson (Ethicon Inc., Somerville, NJ), overseeing the company’s global strategic marketing. Prior to this, he was the Regional Marketing Manager at Johnson & Johnson (Ethicon Inc., Paris, France), responsible for the strategic marketing for Europe, the Middle East, and Africa. During his tenure, both companies enjoyed continuous growth in revenues and new product launches (both from internal R&D and M&A). Prior to this, Harel held several management positions in marketing and sales at Johnson & Johnson Medical Israel.

Harel was recently recognized among the Top 25 Voices in Healthcare Robotics by BIS Research and InsightMonk. He is a guest speaker for management and innovation courses at leading universities in the United States and Israel. Harel holds a Bachelor of Science (BS) from Siena College (USA) and a Master’s in Business Administration (MBA) from Manchester University (UK).

Chen is a seasoned leader in the healthcare space with vast experience in management and operational positions. Throughout her career, Chen contributed to, and played an instrumental part of, the Israeli biomed industry’s continuous growth.

Prior to leading XACT, Chen served as the Executive Director of BioJerusalem, an initiative of the Prime Minister’s Office of the government of Israel to foster the biomed industry in Jerusalem, where she established numerous ventures and collaborations. Before BioJerusalem, Chen served as the CEO of Biomagnesium Systems Ltd., an early stage medical device company. Prior to this, Chen played a key role in the establishment of BioLineRx, Israel’s first Biomed Incubator (now a TASE publicly traded company).

Chen started her career in policy research, helping shape important government biomed industry support schemes. Chen is a member of the founding and steering committee of Women in the Life Sciences Organization (WLSO) in Israel.

Chen holds a BA degree in International Relations and an MBA in Finance, both from the Hebrew University of Jerusalem.

Shai is a well-established executive with more than 20 years of management experience, which includes finance and accounting, developing business growth strategies, maximizing operating margins as well as building strong, diverse teams.

Prior to joining XACT, Shai was Head of Finance for Marvell Israel. Before this, Shai was the CFO at Wavion Networks. Most recently, Shai held a few key positions at Nanomotion, starting as CFO, VP Operations and then followed by a General Manager position.

Shai holds a B.A. in Economics and Accounting from Haifa University, Israel.

Chris has nearly 30 years of experience in the medical device industry, including a broad range of commercial responsibilities with both start-up and global organizations.

Prior to joining XACT Robotics, Chris served as Regional Vice President of Sales with Merit Medical where he managed a direct sales team, clinical associates, and distributor partners across 23 states. Prior to that, Chris worked in leadership roles with other leading medical technology and healthcare companies including Monteris Medical, Invuity, Applied Medical, Endocare, Kyphon, Cyberonics and U.S. Surgical.

Chris also has clinical experience working in a variety of areas including interventional radiology, urology, cardiology, neurology, endocrinology, spine and oncology.

Tzuriel brings 15 years of global operational leadership experience in the medical industry.

Prior to his role at XACT Robotics, Tzuriel served as VP Operations of Adin Group, a global leader in the design and manufacturing of dental implant solutions, where he led the company’s global operations strategy.

Before Adin Group, Tzuriel served as a Director of Operations – Factory Manager at the Israel Defense Force (IDF), where he held several senior operations positions.

Tzuriel holds B-Tech degree in Electrical Engineering from Ort Braude College and an MBA in Business Administration from the College of Management Academic Studies (COMAS).

Sigal is a highly accomplished Human Resources leader with 20+ years of global human resources experience primarily in the medical industry. Sigal brings rich expertise in multi-faceted HR methodologies, with responsibility of the company’s human resources with an emphasis on developing and managing talent, cultivating organizational culture, implementing adequate infrastructure and guiding executive processes to meet organizational goals.

Prior to joining XACT Robotics, Sigal was Vice President of Human Resources at ColorChip.  Sigal held senior Human Resource leadership roles at Syneron-Candela and numerous HR and Project Management leadership positions in various global hi-tech companies.

Sigal holds a B.A. in Business Administration and Human Resources from The Open University, Israel.

Harel is a seasoned executive and entrepreneur in the healthcare space, with an extensive and proven track record. Harel brings over 19 years of experience in leadership positions in the corporate world as well as the start-up sector, including the United States, Europe, and Israel. Harel founded MEDX Ventures Group in 2010, a unique investment and management firm, and serves as its Company Group Chairman.

Harel founded XACT Robotics in 2013 and serves as its Executive Chairman and President. He also serves as the CEO, President & Chairman of Microbot Medical Inc. (Nasdaq: MBOT), where he co-founded the company in 2011 and led it through its successful listing on NASDAQ in 2016. In addition, Harel is the founder and Chairman of MEDX Xelerator LP, a government supported medical devices incubator in Israel, with a partnership between MEDX Ventures Group, Boston Scientific Corporation, Intellectual Ventures, and Sheba Medical Center. Until 2013, Harel served on the board of directors at ConTIPI Ltd., and played an instrumental role in its commercial efforts, resulting in its acquisition by Kimberly Clark Corporation.

Until 2010, Harel served as a Worldwide Group Marketing Director at Johnson & Johnson (Ethicon Inc., Somerville, NJ), overseeing the company’s global strategic marketing. Prior to this, he was the Regional Marketing Manager at Johnson & Johnson (Ethicon Inc., Paris, France), responsible for the strategic marketing for Europe, the Middle East, and Africa. During his tenure, both companies enjoyed continuous growth in revenues and new product launches (both from internal R&D and M&A). Prior to this, Harel held several management positions in marketing and sales at Johnson & Johnson Medical Israel.

Harel was recently recognized among the Top 25 Voices in Healthcare Robotics by BIS Research and InsightMonk. He is a guest speaker for management and innovation courses at leading universities in the United States and Israel. Harel holds a Bachelor of Science (BS) from Siena College (USA) and a Master’s in Business Administration (MBA) from Manchester University (UK).

Chen is a seasoned leader in the healthcare space with vast experience in management and operational positions. Throughout her career, Chen contributed to, and played an instrumental part of, the Israeli biomed industry’s continuous growth.

Prior to leading XACT, Chen served as the Executive Director of BioJerusalem, an initiative of the Prime Minister’s Office of the government of Israel to foster the biomed industry in Jerusalem, where she established numerous ventures and collaborations. Before BioJerusalem, Chen served as the CEO of Biomagnesium Systems Ltd., an early stage medical device company. Prior to this, Chen played a key role in the establishment of BioLineRx, Israel’s first Biomed Incubator (now a TASE publicly traded company).

Chen started her career in policy research, helping shape important government biomed industry support schemes. Chen is a member of the founding and steering committee of Women in the Life Sciences Organization (WLSO) in Israel.

Chen holds a BA degree in International Relations and an MBA in Finance, both from the Hebrew University of Jerusalem.

Sheldon is an entrepreneur bringing over forty years of investing and leadership experience to XACT Robotics. He is the CEO and Chief Investment Officer of Chasing Value Asset Management, Inc. based in California. Over the past twenty years one of his primary investment focuses has been in the field of robotic medical devices. His initial foray into Intuitive Surgical in 2000, led to exponential returns and resulted in continued pursuit of companies with similar vision and quality management. He followed this up with investment in Mako Robotics (acquired by Stryker Corp. in 2013), Mazor Robotics (acquired by Medtronic in 2018), and most recently Corindus Vascular Robotics (acquired by Siemens in 2019). Chasing Value currently has significant holdings in multiple other companies in the medical robotic sector.

In addition to his specific knowledge of the medical technology sector, he is a California Licensed Architect, having worked with all levels of government and Fortune 100 companies on complex projects. Sheldon graduated from the University of Southern California in 1979 with a Bachelor of Architecture. He has written over 1,300 articles on investing and donates his time to local colleges and universities, educating the next generation on business and investment.

During the past 30 years, Mr. Yossi Bornstein has played key roles in the Israeli biomed industry.

He was the General Manager of Bristol-Myers Squibb (Israel).

Mr. Bornstein is the CEO and the founder of Shizim Group, a life science holding company. He is the Founder of ShizimXL & ShizimVS, international innovation centers for medical devices & digital health. He is the Chairman of GCP Clinical Studies Ltd., one of the top providers of clinical research services and educational programs in Israel. He served as the Biotechnology Committee Chairman of the United States-Israel Science & Technology Commission (the “USISTC”). Mr. Bornstein is the founder of ILSI – Israel Life Science Industry Organization (who was integrated into IATI) and Founder of ITTN – Israel Tech Transfer Organization. He is a Co-Founder and director of Microbot Medical (NASDAQ: MBOT)

Yoav has more than 20 years of entrepreneurial experience working with private and publicly traded technology companies. As a partner and CFO at leading Israeli VC funds that include recently Medica Venture Partners and previously, Cedar Fund and Star Ventures, he has worked with start-up companies from their very early stages all the way to successful exits. His hands-on experience includes all aspects of finance and operations including tax planning and reporting, cash management, reporting to limited partnerships under US GAAP rules, investor relations, and has expertise in strategy, financial and legal due diligence, general and financial management, team-building, monitoring portfolio companies, raising capital and M&A.

Yoav holds a B.Sc. in Statistics and Accounting and an MBA with a specialization in Information Systems, both from Tel Aviv University.

Prof. Nahum Goldberg is the Vice-Chairman for the Research Department of Radiology at Hadassah Hebrew University Medical Center, Jerusalem, Israel. His primary research interests focus upon uncovering methods to improve tumor ablation studies. As the Unit Head of Image-guided Therapy at Hadassah, he also has considerable experience with clinical trials and interventional oncologic techniques.

Prof. Goldberg was named a Fulbright Scholar and Fellow of the Society of Interventional Radiology and served on multiple national and international committees advancing interventional oncology. ​

Prof. Goldberg’s external academic appointments and awards include Professor at Harvard University since 2007 and a Clinical and Research Fellowship in abdominal imaging and interventional radiology at Massachusetts General Hospital.

Dr. Morag currently serves as Chairman of Radiology at Assuta Ashdod Medical Center, Ashdod Israel.

Previously, Dr. Morag served as the Regional Radiology Director at Mercy Health Partners Hospitals in Toledo, Ohio. He was a senior member of University Radiology Group (one of the largest private Radiology groups in the U.S.).

Dr. Morag is a graduate of Boston University School of Medicine. He completed both his Radiology residency as well as Fellowship in Cardiovascular & Interventional Radiology at the Beth Israel Deaconess Medical Center & Harvard Medical School.

Following his clinical training, Dr. Morag joined a private practice in western Massachusetts where he served as Chief of Radiology at Holyoke Medical Center for several years.

Dr. Morag has extensive international experience developing and establishing radiology-related businesses. Those include teleradiology, Interventional Radiology services, and free-standing imaging centers.

Dr. Morag is certified by the American Board of Radiology and is currently involved as a consultant and co-founder in several Israeli startup companies ranging from AI to medical devices.